BETH SEIDENBERG
Managing Director at Westlake Village BioPartners
About
Beth Seidenberg is a Managing Director at Westlake Village BioPartners, a leading venture capital firm focused on life sciences. She specializes in creating and investing in groundbreaking biotechnology and pharmaceutical companies. Her expertise spans drug discovery, clinical development, and company building.
Experience
Deep Dive
Beth Seidenberg stands as a prominent figure in the life sciences investment landscape, serving as a Managing Director at Westlake Village BioPartners. Her role at the firm involves not only identifying and funding promising new ventures but also actively participating in their creation and development. Westlake Village BioPartners is a venture capital firm dedicated to building and investing in innovative life science companies, and Dr. Seidenberg's deep operational and medical expertise is central to its mission.
Dr. Seidenberg's investment focus is primarily on early stage biotechnology and pharmaceutical companies that are developing novel therapeutics to address significant unmet medical needs. She is particularly adept at recognizing scientific breakthroughs with the potential to transform patient care, guiding these companies from concept through clinical development and beyond. Her strategic vision helps shape the future of medicine by backing ventures poised to deliver groundbreaking treatments.
Before co-founding Westlake Village BioPartners, Beth Seidenberg had a distinguished career that bridged both large pharmaceutical companies and venture capital. She was a highly influential Partner at Kleiner Perkins (KPCB), where she played a pivotal role in co-founding and investing in numerous successful biotech companies. Her tenure at KPCB solidified her reputation as a visionary investor capable of nurturing nascent ideas into industry leaders.
Prior to her venture capital career, Dr. Seidenberg held senior leadership positions in global pharmaceutical development. She served as Senior Vice President, Head of Global Development at Amgen, one of the world's leading biotechnology companies. Before Amgen, she was Senior Vice President, Head of Global Development and Chief Medical Officer at Tularik. Her extensive background also includes significant roles at Bristol-Myers Squibb and Merck Research Laboratories. This rich operational experience, combined with her medical doctor (MD) degree, provides her with an unparalleled understanding of the drug discovery and development process.
Among her notable contributions, Dr. Seidenberg has been instrumental in the founding and growth of several high-profile companies. These include Acelyrin, Neumora, Septerna, and T-knife Therapeutics, among others. Her ability to identify, build, and scale these enterprises underscores her profound impact on the biotechnology sector. Beth Seidenberg continues to drive innovation, leveraging her expertise to foster the next generation of life science breakthroughs.
Frequently Asked Questions
Who is Beth Seidenberg?
Beth Seidenberg is a highly respected Managing Director at Westlake Village BioPartners, a venture capital firm specializing in life sciences. She is a physician, experienced drug developer, and a prolific investor known for founding and funding innovative biotechnology companies.
What does Beth Seidenberg invest in?
Beth Seidenberg primarily invests in early stage life science companies, focusing on novel therapeutics, drug discovery, and clinical development. Her portfolio includes biotechnology and pharmaceutical ventures aimed at addressing significant unmet medical needs.
Where does Beth Seidenberg work?
Beth Seidenberg works as a Managing Director at Westlake Village BioPartners. This venture capital firm is dedicated to creating and investing in new life science companies, primarily in the biotechnology and pharmaceutical sectors.